Propylthiouracil-induced vasculitis.

Area of Science:

• Rheumatology and Immunology
• Dermatology
• Endocrinology

Background:

• Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a systemic autoimmune disease affecting small blood vessels.
• Pharmaceutical agents are an emerging cause of vasculitis, necessitating careful drug-induced etiology investigation.
• Graves' disease, an autoimmune thyroid condition, is managed with antithyroid drugs like propylthiouracil (PTU).

Observation:

• A 41-year-old woman with Graves' disease developed severe, painful, blistering skin lesions after nearly two years of PTU treatment.
• Workup showed mild perinuclear ANCA elevation and protein S deficiency; biopsy confirmed thrombotic vasculitis.
• The patient's presentation was consistent with propylthiouracil-induced vasculitis.

Findings:

• Discontinuation of PTU was the primary step, but the patient required additional treatments.
• Corticosteroids were administered to manage the severe inflammatory vasculitic process.
• Tissue debridement was necessary due to the extensive skin damage.

Implications:

• This case underscores the importance of considering drug-induced vasculitis, particularly PTU-induced vasculitis, in patients with autoimmune conditions.
• The findings support the timely use of corticosteroids as a crucial component in managing severe PTU-induced vasculitis, beyond just drug cessation.
• Further research is warranted to establish definitive treatment guidelines for this uncommon but serious adverse drug reaction.